Cargando…
Fluorescent advanced glycation end products in type 2 diabetes and its association with diabetes duration, hemoglobin A1c, and diabetic complications
BACKGROUND: Fluorescent advanced glycation end products (fAGEs) are generated through the Maillard reaction between reducing sugars and amino compounds. fAGEs accumulation in human bodies have been confirmed to be related to many chronic diseases. To date, the correlations between serum fAGEs levels...
Autores principales: | Liu, Rui, Zhang, Mengyao, Xu, Li, Liu, Jingjin, Yang, Pingan, Li, Min, Qin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797537/ https://www.ncbi.nlm.nih.gov/pubmed/36590223 http://dx.doi.org/10.3389/fnut.2022.1083872 |
Ejemplares similares
-
Advanced glycation end products in diabetic retinopathy and phytochemical therapy
por: Kang, Qingzheng, et al.
Publicado: (2022) -
Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014) -
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
por: Rhee, Sang Youl, et al.
Publicado: (2018) -
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
por: Guerin-Dubourg, Alexis, et al.
Publicado: (2017) -
Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
por: Mengstie, Misganaw Asmamaw, et al.
Publicado: (2022)